Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical I... ( NEW YORK Jan. 4 /- Berkery Noyes ...)

HOME >> MEDICINE >> TECHNOLOGY

Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information

Date:1/4/2008

NEW YORK, Jan. 4 /PRNewswire/ -- Berkery Noyes announced today that the firm represented The Thomson Corporation (NYSE: TOC; TSX: TOC) in the sale of CenterWatch ("CW") and New England Institutional Review Board ("NEIRB") to Jobson Medical Information, a portfolio company of The Wicks Group, LLC. Terms of the transaction were not disclosed.

Founded in 1994, CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be assessed by patients and their advocates.

The NEIRB division provides FDA mandated services to pharmaceutical companies and Contract Research Organizations (CRO's). Founded in 1988, NEIRB was one of the first central institutional review boards established to meet the ethical review needs of a burgeoning drug development market.

"Both CW and NEIRB are winning franchises in the healthcare market and both have high caliber management and employees," said Tom O'Connor, the Berkery Noyes Managing Director who managed the transaction on behalf of The Thomson Corporation. "Within Jobson Medical Information portfolio these assets can grow and expand," added O'Connor.

Berkery Noyes acted as exclusive financial advisor to The Thomson Corporation on the sale of CenterWatch and NEIRB. Berkery Noyes has been involved with many of the most notable transactions in the healthcare, pharmaceutical tools and services, and medical marketing sectors involving both strategic and financial buyers and sellers.

About Berkery Noyes -- Berkery Noyes is one of
'/>"/>

SOURCE Berkery Noyes
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2
Related medicine technology :

1. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
4. Immunosyn Corporation Releases SF-1019 Study Results
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
9. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
10. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference

Post Your Comments:

(Date:11/25/2009)... Swissray International, Inc. a le... ddR ) systems, announced today that its operation...ith a long term view towards growing Swissray,s me...assets and intellectual property, as well as contr...growth Swissray is now poised to move to the next ...

(Date:11/25/2009)...wswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA... products for minimally disruptive surgical treatm...ost a conference call on Monday, November 30, 2009...call will focus on current issues relative to reim...ude comments from management followed by a short q...

(Date:11/25/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Pain Management - Global Trends ,, h...t---Global-Trends.html ,, Widespread availabil... clinics, and the advent of new drugs have acceler...ket. Healthcare reforms and reimbursement structur...

Breaking Medicine Technology:Swissray International Announces New Ownership 2 NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2 NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3 NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4 Reportlinker Adds Pain Management - Global Trends 2 Reportlinker Adds Pain Management - Global Trends 3 Reportlinker Adds Pain Management - Global Trends 4 Reportlinker Adds Pain Management - Global Trends 5 Reportlinker Adds Pain Management - Global Trends 6 Food Allergy Facts Need More Focus 53836 1 Food Allergy Facts Need More Focus 53836 2 China Sky One Medical Inc Appoints New Independent Director 13412 1 China Sky One Medical Inc Appoints New Independent Director 13412 2 China Sky One Medical Inc Appoints New Independent Director 13412 3 Inpatient Management Inc and Reid Hospital Achieve Performance Improvement and Cost Savings 53830 1 Inpatient Management Inc and Reid Hospital Achieve Performance Improvement and Cost Savings 53830 2

[0] Swissray International Announces New Ownership [0] NuVasive Announces Conference Call and Webcast Regarding Reimbursement [0] Reportlinker Adds Pain Management - Global Trends

...egimen of Androgen Deprivation and, Chemotherapy R...han Half - - Data Further Confirm Bavituximab,s ...ation Regimens for Cancer Therapy -, ATLANTA, and...s, Inc. (Nasdaq: PPHM ), a clinical stage,biophar...antibodies for the,treatment of cancer and hepatit...

...Antibiotics Against ,Superbugs, BOSTON, Sept. 6 ...ege of Engineering may have discovered the path,to...so-called "superbugs,",bacteria that have develope...s have discovered a previously unknown chain of ev...ew avenues of research., Currently, three classes...

Other Medicine Technology:Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 2 Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 3 Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 4 Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2 Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3

Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease Boston University Biomedical Engineers Find Chink in Bacteria's Armor

(Date:11/29/2009)...ound of treatment equals a $41,000 pay raise, rese...hDay News) -- Psychological therapy may be much mo... raise or winning a lottery prize, suggests an Eng...sands of people who provided information about the...n happiness from a $1,329 course of therapy was so...

(Date:11/28/2009).... 28 Welcome to syngo® ...linical routine from Siemens Healthcare. As th...tem (PACS) from Siemens where 2D, 3D, and 4D rea... is poised to change the way multimodality images ...on at the 95th Scientific Assembly and Annual Me...

(Date:11/28/2009)... lift spirits, recognize signs of depression , ... many seniors, the holiday season can trigger mela...le with health issues or worry about money problem..., To help overcome the seasonal blues, the AGS F... advice: , Get out and socialize or invite famil...

(Date:11/27/2009)...7 Considered a highly r...ears ago, solid organ transplantation is now a lif...rdinary men and women who gathered at the Winspear...gether from medical centers around the world to ce...ansplant Institute (BRTI), one of the pioneers of ...

(Date:11/27/2009)... Israel, Nov. 27 Shamir ...), a leading provider of innovative products and t... today that its board of directors had declared a ...$ 10 million (approximately NIS 37.62 million base...exchange), or approximately US$ 0.609 (approximate...

Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2 Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2 Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3 Health News:Seniors May Need Help Overcoming Holiday Blues 2 Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2 Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3 Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2 Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3

[0] Psychotherapy Can Boost Happiness More Than Money: Study [0] Siemens Healthcare Unveils syngo.plaza at RSNA 2009 [1] Seniors May Need Help Overcoming Holiday Blues [0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary [0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend

...portant for those who have headaches with aura, re...thDay News) -- Scientists say they,ve spotted a ge.... , However, the risk is still there, and if the p...f migraine with aura with this gene, but if you ha...

...iliated Computer Services,Inc. (NYSE: ACS ) today...lion, with UMass Memorial Health Care, Inc., a Wor...vide extensive information,systems services. The c...ing UMass Memorial,s IT systems through planned de...

...ly 31 HCA today announced financial,and operating...8., Second Quarter Summary:, -- Revenues increa...totaled $141 million, compared to $116 million in ...aries and benefits increased to $2.841 billion, fr...

...31 Go Healthy, Inc. (Pink,Sheets: GOHE) announced...ecognition from the Texas Chiropractic Association...t presentations before the association as well,as ...r. Thomas Klesmit, Legislative Director of the TCA...

...ner Dental Management,Services, Inc. (Nasdaq: BDM...ill conduct a conference call to review second qua...esults, the teleconference may include,discussion ...to 1-866-814-1919; refer to Birner Dental Manageme...

...y 31 Osteotech, Inc.,(Nasdaq: OSTE ), a leader i...nerative healing, reported today that net income f...illion, or $.10 diluted earnings per share,compare...reased 4% to $27.6 million from $26.5 million for ...

Gene Could Boost Stroke Risk for Migraine Sufferers ACS Signs Five-Year, $100 Million Deal to Provide Technology Services to UMass Memorial Health Care, Inc.HCA Reports Second Quarter 2008 Results Go Healthy Receives Letter of Recognition From the Texas Chiropractic Association Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Second Quarter 2008 Results Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million

Wright stain

Albumin Reagent Set

AST (SGOT) Reagent Set (UV-Kinetic Method)

AST GOT Reagent

Medicine Products:

Wright stain Albumin Reagent Set AST (SGOT) Reagent Set (UV-Kinetic Method)AST GOT Reagent

Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical I...( NEW YORK Jan. 4 /- Berkery Noyes ...),Health